SANJIB DEY: Open Payments
NPI 1609491968 · HAUPPAUGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$971 in 44 payments from 13 companies in 2025. Trend: 2023 $447 · 2024 $1,144 · 2025 $971
Food & beverage: $902Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $267 |
| Novo Nordisk Inc | 8 | $173 |
| Astellas Pharma US Inc | 4 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| PFIZER INC. | 4 | $79 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| Exact Sciences Corporation | 1 | $29 |
| SHIELD THERAPEUTICS INC | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: VRAYLAR, CAPLYTA, Veozah, Rybelsus, TRUMENBA, GARDASIL 9, ZEPBOUND, Ozempic.
Industry payments across NY — which companies pay providers there.
